Clinical Trials Browser

Completed × 4-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid × Clear all

NCT04657120 2025-12-23

HYDRA

Cardiovascular Diseases, Disease, Embolism, Lung Diseases, Neoplasms, Pulmonary Embolism, Respiratory Tract Diseases, Vascular Diseases, Embolism and Thrombosis